Bicycle Therapeutics Correlations

BCYC Stock

USD 11.10 0.15 1.33%

The current 90-days correlation between Bicycle Therapeutics and AnaptysBio is 0.14 (i.e., Average diversification). The correlation of Bicycle Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Bicycle Therapeutics Correlation With Market

Significant diversification

The correlation between Bicycle Therapeutics and DJI is 0.08 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Bicycle Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bicycle Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

For information on how to trade Bicycle Stock refer to our How to Trade Bicycle Stock guide.

Moving together with Bicycle Stock

0.67	INZY	Inozyme Pharma	Pair Corr
0.76	KURA	Kura Oncology	Pair Corr
0.95	ABOS	Acumen Pharmaceuticals	Pair Corr
0.93	ADTX	Aditxt Inc	Pair Corr
0.68	ANAB	AnaptysBio	Pair Corr
0.9	STRO	Sutro Biopharma	Pair Corr
0.94	TCRX	Tscan Therapeutics	Pair Corr
0.76	TERN	Terns Pharmaceuticals	Pair Corr
0.84	CRNX	Crinetics Pharmaceuticals Earnings Call Today	Pair Corr
0.8	DAWN	Day One Biopharmaceu	Pair Corr
0.71	TLKMF	Telkom Indonesia Tbk	Pair Corr

Moving against Bicycle Stock

0.74	PHGE	Biomx Inc	Pair Corr
0.7	OPT	Opthea Earnings Call Today	Pair Corr
0.67	PFE	Pfizer Inc Aggressive Push	Pair Corr
0.67	GANX	Gain Therapeutics	Pair Corr
0.62	LTRN	Lantern Pharma	Pair Corr
0.6	FENC	Fennec Pharmaceuticals	Pair Corr
0.53	CUE	Cue Biopharma	Pair Corr
0.37	A	Agilent Technologies Earnings Call Today	Pair Corr
0.34	XFOR	X4 Pharmaceuticals	Pair Corr
0.69	CGTX	Cognition Therapeutics	Pair Corr
0.58	DBVT	DBV Technologies Earnings Call This Week	Pair Corr
0.37	CPRX	Catalyst Pharmaceuticals Earnings Call Today	Pair Corr
0.83	SSNLF	Samsung Electronics	Pair Corr
0.8	OBI	Ondine Biomedical	Pair Corr
0.66	GPI	Group 1 Automotive	Pair Corr
0.59	EC	Ecopetrol SA ADR Earnings Call Today	Pair Corr

Related Correlations Analysis

	IDYA	ANAB	MGTX	KROS	FIXX	TNYA	IGMS	GLUE	STOK	MRUS
IDYA		0.43	-0.39	0.76	0.0	0.78	0.89	0.79	0.72	0.41	IDYA
ANAB	0.43		0.2	0.81	0.0	0.74	0.53	0.75	0.38	0.62	ANAB
MGTX	-0.39	0.2		-0.17	0.0	-0.18	-0.32	-0.04	-0.14	0.36	MGTX
KROS	0.76	0.81	-0.17		0.0	0.91	0.84	0.89	0.57	0.56	KROS
FIXX	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	FIXX
TNYA	0.78	0.74	-0.18	0.91	0.0		0.85	0.89	0.6	0.52	TNYA
IGMS	0.89	0.53	-0.32	0.84	0.0	0.85		0.87	0.66	0.55	IGMS
GLUE	0.79	0.75	-0.04	0.89	0.0	0.89	0.87		0.72	0.6	GLUE
STOK	0.72	0.38	-0.14	0.57	0.0	0.6	0.66	0.72		0.18	STOK
MRUS	0.41	0.62	0.36	0.56	0.0	0.52	0.55	0.6	0.18		MRUS
	IDYA	ANAB	MGTX	KROS	FIXX	TNYA	IGMS	GLUE	STOK	MRUS

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

TNYA	+ 0.91	KROS
IGMS	+ 0.89	IDYA
GLUE	+ 0.89	KROS
GLUE	+ 0.89	TNYA
GLUE	+ 0.87	IGMS
IGMS	+ 0.85	TNYA

High negative correlations

MGTX	- 0.39	IDYA
IGMS	- 0.32	MGTX
TNYA	- 0.18	MGTX
KROS	- 0.17	MGTX
STOK	- 0.14	MGTX
GLUE	- 0.04	MGTX

Risk-Adjusted Indicators

There is a big difference between Bicycle Stock performing well and Bicycle Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Bicycle Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
IDYA	2.28	(0.32)	0.00	7.20	0.00	0.00	4.37	(4.64)	13.32
ANAB	4.92	0.13	0.02	0.25	7.07	(5.56)	9.45	(9.33)	42.28
MGTX	2.60	0.28	0.08	(2.74)	3.06	(2.74)	5.56	(5.15)	15.50
KROS	4.16	(1.46)	0.00	(2.61)	0.00	0.00	5.53	(7.31)	82.94
FIXX	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
TNYA	5.79	(0.49)	0.00	(0.11)	0.00	0.00	14.63	(7.14)	75.41
IGMS	5.26	(2.18)	0.00	(0.55)	0.00	0.00	8.99	(11.14)	76.54
GLUE	3.77	(0.30)	0.00	(0.21)	0.00	0.00	8.40	(8.27)	23.57
STOK	3.37	(0.42)	0.00	6.99	0.00	0.00	7.03	(9.08)	27.59
MRUS	2.09	0.04	0.01	(0.05)	2.61	(2.34)	5.15	(4.78)	15.98

Bicycle Therapeutics Corporate Management

Kevin MBA	CEO Director	Profile
CBE FMedsci	NonEx CoFounder	Profile
Christian Heinis	Scientific Founder	Profile
Stephanie Yao	Senior Communications	Profile
Alistair Milnes	Chief Officer	Profile
Gillian Langford	Head Management	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC